MedPath

Dotatate

Generic Name
Dotatate
Drug Type
Small Molecule
Chemical Formula
C65H90N14O19S2
CAS Number
177943-88-3
Unique Ingredient Identifier
MRL3739G66

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2024/05/03
Phase 2
Not yet recruiting
Sinotau Pharmaceutical Group
2023/06/08
Phase 2
Not yet recruiting
Peking University
2023/06/01
Phase 3
Recruiting
2023/05/30
Phase 2
Active, not recruiting
2022/07/15
Phase 3
Active, not recruiting
Sinotau Pharmaceutical Group
2020/03/06
Phase 2
Not yet recruiting
2019/08/29
Phase 2
Recruiting
2018/11/20
N/A
Completed
2016/06/24
N/A
Withdrawn
2015/09/10
Not Applicable
Completed
Marcelo F. Di Carli, MD, FACC

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath